G. Schellong

Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

Alfred Reiter, Martin Schrappe, Wolfgang Ludwig et al. · PubMed · 2000 · 365 citations

High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90

G. Schellong, Richard Pötter, Jürgen Brämswig et al. · Journal of Clinical Oncology · 1999 · 248 citations

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

U. Creutzig, M Zimmermann, J. Ritter et al. · Leukemia · 2005 · 228 citations

Neonatology, Pediatric Epidemiology, Pediatric Hematology +8

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence

Jürgen Brämswig, Ulrike Heimes, Elisabeth Heiermann et al. · Cancer · 1990 · 172 citations

Spermatogenesis, Fertility, Reproductive Health +19

Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87

Ursula Creutzig, Jochen Harbott, Christian Sperling et al. · Blood · 1995 · 171 citations · Full text